Sai Life Sciences Ltd Stock Price Today (NSE: SAILIFE)
Fundamental Score
Sai Life Sciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sai Life Sciences Ltd share price today is ₹1213.50, up +0.60% on NSE/BSE as of 17 June 2026. Sai Life Sciences Ltd (SAILIFE) is a Mid-cap company in the Pharmaceuticals sector with a market capitalisation of ₹18.38K (Cr). The 52-week high for SAILIFE share price is ₹1184.80 and the 52-week low is ₹716.60. At a P/E ratio of 64.17x, SAILIFE is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 11.05% and a debt-to-equity ratio of 0.18.
Sai Life Sciences Ltd Share Price Chart — NSE/BSE Historical Performance
Sai Life Sciences Ltd share price chart: 5.99% return over the past month. 52-week high ₹1184.80, 52-week low ₹716.60.
Sai Life Sciences Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1139.10 | ₹1144.50 | ₹1116.70 | ₹1128.30 | 2.96L (Cr) | |
| ₹1175.00 | ₹1175.60 | ₹1127.10 | ₹1145.20 | 4.88L (Cr) | |
| ₹1139.80 | ₹1169.90 | ₹1126.00 | ₹1160.00 | 6.29L (Cr) | |
| ₹1131.20 | ₹1131.20 | ₹1131.20 | ₹1131.20 | 0.00 (Cr) | |
| ₹1141.00 | ₹1150.00 | ₹1116.30 | ₹1131.20 | 3.78L (Cr) | |
| ₹1170.00 | ₹1171.00 | ₹1120.30 | ₹1141.00 | 10.01L (Cr) | |
| ₹1116.90 | ₹1184.80 | ₹1108.50 | ₹1175.90 | 8.52L (Cr) | |
| ₹1138.10 | ₹1138.10 | ₹1102.00 | ₹1113.80 | 1.81L (Cr) | |
| ₹1151.00 | ₹1153.30 | ₹1115.00 | ₹1138.10 | 5.54L (Cr) | |
| ₹1125.40 | ₹1151.00 | ₹1112.20 | ₹1141.30 | 5.99L (Cr) |
Sai Life Sciences Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1175.00 | ₹1175.60 | ₹1116.70 | ₹1128.30 | -3.97% | |
| ₹1081.20 | ₹1184.80 | ₹949.30 | ₹1160.00 | +7.29% | |
| ₹1000.00 | ₹1089.90 | ₹927.05 | ₹1069.45 | +6.95% | |
| ₹992.50 | ₹1084.00 | ₹938.00 | ₹972.00 | -2.07% | |
| ₹847.70 | ₹1004.70 | ₹783.85 | ₹998.25 | +17.76% | |
| ₹905.00 | ₹983.35 | ₹791.10 | ₹835.15 | -7.72% | |
| ₹890.00 | ₹924.00 | ₹845.60 | ₹908.40 | +2.07% | |
| ₹917.80 | ₹938.85 | ₹846.05 | ₹884.40 | -3.64% | |
| ₹860.50 | ₹939.95 | ₹839.25 | ₹918.20 | +6.71% | |
| ₹829.80 | ₹923.40 | ₹821.10 | ₹860.70 | +3.72% | |
| ₹814.00 | ₹943.00 | ₹778.50 | ₹824.70 | +1.31% | |
| ₹780.00 | ₹853.50 | ₹764.40 | ₹808.45 | +3.65% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Sai Life Sciences Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sai Life Sciences Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SAILIFE across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Operating Margins (19.31%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (101.98%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (35.88%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (18.49% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (17.57% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.18)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (7.88x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Institutional Confidence (FII+DII: 52.44%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Premium Valuation Risk (P/E: 64.17x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Negative Free Cash Flow (₹-224.76 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Sai Life Sciences Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Sai Life Sciences Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Sai Life Sciences LtdSai Life Scienc...Selected✓ SAILIFE • 544306 | 48.6/100 | ₹1213.50₹1214 | ₹18378.84₹18378.84 | 64.17Average 64.2 Average | 11.05%Average 11.05% Average | 14.05%Average 14.05% Average | 0.18Excellent 0.2 Excellent | 17.57%Excellent 17.57% Excellent | 18.49%Excellent 18.49% Excellent | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1882.30₹1882 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4460.10₹4460 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1335.20₹1335 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2287.40₹2287 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2492.60₹2493 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Sai Life Sciences Ltd PE Ratio History
Historical price-to-earnings ratio for SAILIFE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹8.61 | ₹908.40 | 105.5x |
| FY 2024 | ₹3.98 | ₹751.20 | 188.7x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Sai Life Sciences Ltd Quarterly Performance
Latest quarterly metrics for SAILIFE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
35.88%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
101.98%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
18.49%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
17.57%
Compounded annual net profit growth over 5 years
Sai Life Sciences Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SAILIFE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Sai Life Sciences Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Sai Life Sciences Ltd (SAILIFE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Sai Life Sciences Ltd
About SAILIFE (Sai Life Sciences Ltd)
Sai Life Sciences Ltd is a globally recognized Contract Research, Development, and Manufacturing Organization deeply rooted in pharmaceutical innovation. From its strategic base in... Hyderabad, India, Sai Life Sciences propels the boundaries of drug discovery and development through a comprehensive suite of services. Their expertise spans the entire pharmaceutical lifecycle, providing customized solutions from initial target identification and lead optimization to advanced drug substance and drug product manufacturing. With a commitment to scientific excellence and agility, Sai Life Sciences partners with pharmaceutical and biotechnology companies of all sizes, accelerating their journeys toward bringing life-saving medications to market. SAILIFE distinguishes itself by integrating cutting-edge technologies and a highly skilled scientific workforce. Their capabilities encompass a wide spectrum of disciplines, including medicinal chemistry, process development, analytical research, and formulation development. This integrated approach allows for seamless transitions between different phases of drug development, ensuring efficiency and minimizing potential delays. Beyond its scientific prowess, Sai Life Sciences places a strong emphasis on regulatory compliance and quality assurance. This dedication ensures that every project adheres to the highest industry standards, providing clients with confidence in the integrity and reliability of their results. Sai Life Sciences operates on a foundation of collaboration and client-centricity. They forge strong partnerships with their clients, working as an extension of their own teams to achieve shared goals. Their focus is on delivering tailored solutions that meet the specific needs of each project, while constantly adapting to evolving market demands. By investing in state-of-the-art infrastructure and attracting top talent, Sai Life Sciences continues to solidify its position as a trusted partner in the global pharmaceutical industry, driving innovation and making a tangible difference in healthcare outcomes worldwide.
Company Details
Key Leadership
Latest News
SAILIFE Share Price: Frequently Asked Questions
What is the current share price of Sai Life Sciences Ltd?
Sai Life Sciences Ltd (SAILIFE) trades at ₹1213.50 on NSE and BSE. Market cap ₹18.38K (Cr). Educational data only.
What is the P/E ratio of Sai Life Sciences Ltd?
Sai Life Sciences Ltd has a P/E of 64.17x vs industry average 31.77x.
What is the Bull Run score for Sai Life Sciences Ltd?
Sai Life Sciences Ltd has a Bull Run score of 48.6/100 based on 25+ financial parameters.
Does Sai Life Sciences Ltd pay dividends?
Sai Life Sciences Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Sai Life Sciences Ltd?
Sai Life Sciences Ltd has ROE of 11.05%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Sai Life Sciences Ltd?
Sai Life Sciences Ltd has debt-to-equity of 0.18.
Is Sai Life Sciences Ltd a good investment?
Bull Run gives Sai Life Sciences Ltd a score of 48.6/100. This is not investment advice — consult a SEBI-registered advisor.